Long-term observation of estimated fluid volume reduction after the initiation of ipragliflozin in patients with type 2 diabetes mellitus: a sub-analysis from a randomized controlled trial (PROTECT)

BACKGROUNDS/AIM: Recent studies have shown that the addition of sodium-glucose co-transporter 2 (SGLT2) inhibitors gradually reduces the estimated fluid volume parameters in a broad range of patient populations, suggesting that this mediates the clinical benefits of SGLT2 inhibitors in preventing he...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Atsushi, Imai, Takumi, Toyoda, Shigeru, Sugimoto, Kazuhiro, Yoshida, Ruka, Furuta, Machi, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326942/
https://www.ncbi.nlm.nih.gov/pubmed/37415229
http://dx.doi.org/10.1186/s13098-023-01129-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326942/
https://www.ncbi.nlm.nih.gov/pubmed/37415229
http://dx.doi.org/10.1186/s13098-023-01129-3

Ejemplares similares